The clinical pattern and treatment of 30 early renal allograft recipients with interstitial pneumonia
10.3760/cma.j.issn.0254-1785.2014.05.007
- VernacularTitle:肾移植后早期间质性肺炎的临床病程进展规律及治疗30例
- Author:
Xiaoxiao WANG
;
Song CHEN
;
Jun YU
;
Lan ZHU
;
Zhengbin LIN
;
Gang CHEN
- Publication Type:Journal Article
- Keywords:
Kidney transplantation;
Interstitial pneumonia;
Cytomegaoviyns
- From:
Chinese Journal of Organ Transplantation
2014;35(5):282-286
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical pattern,therapeutic principle and influencing factors of interstitial pneumonia in renal allograft recipients.Method The general information,clinical manifestation,treatment and outcomes of 30 recipients with interstitial pneumonia after renal transplantation from Nov.2006 to Dec.2013 were analyzed retrospectively.Result Twenty-nine of 30 patients developed interstitial pneumonia between 2 to 6 months post-transplant.The total course of the pneumonia lasted for 34.9 ± 7.5 days on average.Chest CT scans were used to monitor severity of interstitial pneumonia each week.The mean duration between the onset to the fastigium of pneumonitis was approximately 14.8 ± 1.9 days.The mean duration of the fastigium lasted for 7.3 ±3.6 days,after that the patients usually started to recover.Deteriorated chest CT scan findings and long terms of the fastigium usually indicated poor outcomes.The mean duration of the recovery period was 13.1 ± 3.7 days.After adjusted administration of methylprednisolone,antibiotics,antifungal agents,nutritional support as well as immunosuppressive drugs,23 patients with mild and moderate pneumonia by the chest CT scans were cured and discharged.However,4 of the 7 patients with severe pneumonia by the chest CT scans died.Conclusion The progression of interstitial pneumonia after renal transplantation is characterized by a more consistent regularity.After adjusted administration of methylprednisolone,antibiotics,antifungal agents,nutritional support as well as immunosuppressive drugs,renal allograft recipients with interstitial pneumonia could obtain a good therapeutic effect without over-treatment.
